Titre
Limits to potent antiretroviral therapy.
Type
synthèse (review)
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Telenti, A.
Auteure/Auteur
Paolo Rizzardi, G.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1052-9276
Statut éditorial
Publié
Date de publication
2000
Volume
10
Numéro
6
Première page
385
Dernière page/numéro d’article
93
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review - Publication Status: ppublish
Résumé
The availability of potent combination antiretroviral therapy (ART), also known as highly active antiretroviral therapy or HAART has changed the prognosis of HIV infection. However, the benefits have to be seen in the context of deficiencies of current therapy: failure to eradicate the virus, the slow and potentially incomplete recovery of the immune system, the high prevalence of resistance, and the potential for long-term toxicity. Treatment strategies need to take into account these limits to better target those HIV-infected patients who could benefit the most from antiretroviral therapy.
PID Serval
serval:BIB_33CC2AA0F3DC
PMID
Date de création
2008-01-25T13:45:34.922Z
Date de création dans IRIS
2025-05-20T20:44:23Z